Small-Molecule Gankyrin Inhibition as a Therapeutic Strategy for Breast and Lung Cancer.
Small-Molecule Gankyrin Inhibition as a Therapeutic Strategy for Breast and Lung Cancer.
复制标题
DOI:
10.1021/acs.jmedchem.2c00190
复制
发表时间:
2022-07-14
影响因子:
7.3
通讯作者:
Muth A
中科院分区:
文献类型:
--
作者:
Kanabar D;Goyal M;Kane EI;Chavan T;Kabir A;Wang X;Shukla S;Almasri J;Goswami S;Osman G;Kokolis M;Spratt DE;Gupta V;Muth A
Gankyrin is an oncoprotein responsible for the development of numerous cancer types. It regulates the expression levels of multiple tumor suppressor proteins (TSPs) in liver cancer, however, gankyrin’s regulation of these TSPs in breast and lung cancer has not been thoroughly investigated. Additionally, no small molecule gankyrin inhibitor has been developed which demonstrates potent antiproliferative activity against gankyrin overexpressing breast and lung cancers. Herein, we are reporting the structure-based design of gankyrin-binding small molecules which potently inhibited the proliferation of gankyrin overexpressing A549 and MDA-MB-231 cancer cells, reduced colony formation, and inhibited the growth of 3D spheroids in an in vitro tumor simulation model. Investigations demonstrated that gankyrin inhibition occurs through either stabilization or destabilization of its 3D structure. These studies shed light on the mechanism of small molecule inhibition of gankyrin and demonstrate that gankyrin is a viable therapeutic target for the treatment of breast and lung cancer.
登录
查看更多内容
影响因子:
4.3
作者:
Higashitsuji, H;Liu, Y;Fujita, J
通讯作者:
Fujita, J
影响因子:
8
作者:
Hui, L.;Zheng, Y.;Foster, D. A.
通讯作者:
Foster, D. A.
影响因子:
14.8
作者:
Greenfield, Norma J.
通讯作者:
Greenfield, Norma J.
影响因子:
3.4
作者:
Gao, Liucun;Xie, Huahong;Song, Haifeng
通讯作者:
Song, Haifeng
影响因子:
4.6
作者:
Daina A;Michielin O;Zoete V
通讯作者:
Zoete V